FDA Approves ENCELTO, a First-of-its-kind Eye Implant That Slows Vision Loss in Rare Eye Disease
June 05, 2025
June 05, 2025
LA JOLLA, California, June 5 (TNSrpt) -- The Scripps Research Institute issued the following news:
* * *
FDA approves ENCELTO, a first-of-its-kind eye implant that slows vision loss in rare eye disease
Cell-based therapy with roots at Scripps Research offers new hope for patients with macular telangiectasia type 2.
*
For people diagnosed with macular telangiectasia type 2 (MacTel)--a rare and slowly progressing retinal disease--the . . .
* * *
FDA approves ENCELTO, a first-of-its-kind eye implant that slows vision loss in rare eye disease
Cell-based therapy with roots at Scripps Research offers new hope for patients with macular telangiectasia type 2.
*
For people diagnosed with macular telangiectasia type 2 (MacTel)--a rare and slowly progressing retinal disease--the . . .